Chronic Rhinosinusitis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CNTB | C | Connect Biopharma Holdings Limited | 3.49 | |
LYRA | F | Lyra Therapeutics, Inc. | 4.19 | |
OPTN | F | OptiNose, Inc. | -2.33 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
DWAS | B | PowerShares DWA SmallCap Technical Leaders Portfolio | 0.02 | |
IWC | B | iShares Microcap ETF | 0.02 | |
IWO | B | iShares Russell 2000 Growth ETF | 0.01 | |
VTWG | B | Vanguard Russell 2000 Growth ETF | 0.01 | |
UWM | C | ProShares Ultra Russell2000 | 0.0 |
Compare ETFs
Related Industries:
Biotechnology
Drug Manufacturers - Specialty & Generic
- Chronic Rhinosinusitis
Chronic rhinosinusitis (CRS) is a long-term inflammation of the nasal passages and sinuses. It is a common condition that affects millions of people worldwide. Symptoms of CRS include nasal congestion, facial pain, postnasal drip, and a decreased sense of smell. Treatment options include medications, nasal irrigation, and surgery.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles